Skip to main content

Meet Aaron

Aaron was diagnosed with moderate hemophilia A shortly after he was born. Because he was the first in his family to be diagnosed with a bleeding disorder, his parents were extra cautious as he was growing up. Aaron didn’t have a peer group to turn to, but eventually he was introduced to the local hemophilia community through his hematology clinic. He became involved and decided he wanted to give back—to help people like him, mentor little kids, and to share his story with parents to give them hope that their children would be okay.

Please see full Prescribing Information.
Individual results may vary.

USA18BIO01041
USA18BIO01041
Play
Pause
Skip
Volume
Chapters
Transcript
References
Subtitles
Fullscreen

Meet Aaron

Chapters
Transcript
References

Aaron was diagnosed with moderate hemophilia A shortly after he was born. Because he was the first in his family to be diagnosed with a bleeding disorder, his parents were extra cautious as he was growing up. Aaron didn’t have a peer group to turn to, but eventually he was introduced to the local hemophilia community through his hematology clinic. He became involved and decided he wanted to give back—to help people like him, mentor little kids, and to share his story with parents to give them hope that their children would be okay.

Please see full Prescribing Information.
Individual results may vary.

Return to overview

Transcripts

Return to overview

References


Selected Important Safety Information

You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins.

Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands.

Indications and Usage

Novoeight® (Antihemophilic Factor [Recombinant]) is an injectable medicine used to control and prevent bleeding in people with hemophilia A. Your healthcare provider may give you Novoeight® when you have surgery.

Novoeight® is not used to treat von Willebrand Disease.

Important Safety Information

You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins.

Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands.

Before taking Novoeight®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII.

Your body can make antibodies called “inhibitors” against Novoeight®, which may stop Novoeight® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Novoeight®.

Common side effects of Novoeight® include swelling or itching at the location of injection, changes in liver tests, and fever.

Please click here for Prescribing Information.

Novoeight® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800- FDA-1088.